DNA-framework-based multidimensional molecular classifiers for cancer diagnosis

Nat Nanotechnol. 2023 Jun;18(6):677-686. doi: 10.1038/s41565-023-01348-9. Epub 2023 Mar 27.

Abstract

A molecular classification of diseases that accurately reflects clinical behaviour lays the foundation of precision medicine. The development of in silico classifiers coupled with molecular implementation based on DNA reactions marks a key advance in more powerful molecular classification, but it nevertheless remains a challenge to process multiple molecular datatypes. Here we introduce a DNA-encoded molecular classifier that can physically implement the computational classification of multidimensional molecular clinical data. To produce unified electrochemical sensing signals across heterogeneous molecular binding events, we exploit DNA-framework-based programmable atom-like nanoparticles with n valence to develop valence-encoded signal reporters that enable linearity in translating virtually any biomolecular binding events to signal gains. Multidimensional molecular information in computational classification is thus precisely assigned weights for bioanalysis. We demonstrate the implementation of a molecular classifier based on programmable atom-like nanoparticles to perform biomarker panel screening and analyse a panel of six biomarkers across three-dimensional datatypes for a near-deterministic molecular taxonomy of prostate cancer patients.

MeSH terms

  • DNA*
  • Humans
  • Male
  • Prostatic Neoplasms* / diagnosis
  • Prostatic Neoplasms* / genetics

Substances

  • DNA